Institutions & companies

Thermo Fisher

Medicine & Biotech · covered by 2 outlets this week · tracked since 2026-10-27

Press: 2 independent outlet-days

Coverage

study

Generation of an induced pluripotent stem cell line, LCSBi021-A, from a Parkinson's disease patient harboring the missense mutation c.213C>G (p.Ser71Arg) in the RAB32 gene

bioRxiv - Cell Biology · 5d ago

Thermo Fisher adds sterile drug product lines, bioprocessing at Massachusetts site

Pharma Manufacturing · 19d ago